EUVIMEDEUVIMED entdecken
Open Access

Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma

Nickolai J Matuschewski iD, Rabea Sobirey iD, Margarita Revzin iD, Tal Zeevi iD, Moritz Gross iD, Victor Kasolowsky iD, Annabella Shewarega iD, Ellen Meister iD, Tabea Kao iD, Jonathan Tefera iD, Khaled Bousabarah iD, Ramesh Batra iD und 8 weitere

Radiology · 2025

DOI: 10.1148/radiol.242750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology, 2025. Verfasst von Nickolai J Matuschewski und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, beta Catenin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative multiparametric contrast-enhanced MRI parameters helped predict molecular profiles of hepatocellular carcinoma via machine learning algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMagnetic Resonance Imagingbeta CateninB7-H1 AntigenBiomarkers, TumorHumansContrast MediaMaleFemaleMiddle AgedAged

Substanzen

Contrast Mediabeta CateninB7-H1 AntigenBiomarkers, TumorCTNNB1 protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520, USA.
  • Department of Radiology, Charité-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet, 10117 Berlin, Germany.
  • Department of Biomedical Engineering, School of Engineering and Applied Sciences, 17 Hillhouse Avenue, New Haven, CT 06520, USA.
  • Visage Imaging GmbH, Lepsiusstraße 70, 12163 Berlin, Germany.
  • Transplantation and Immunology, Department of Surgery, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
  • Department of Medicine, Liver Center, Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520, USA.

ORCID-Profile: Nickolai J Matuschewski, Rabea Sobirey, Margarita Revzin, Tal Zeevi, Moritz Gross, Victor Kasolowsky, Annabella Shewarega, Ellen Meister, Tabea Kao, Jonathan Tefera, Khaled Bousabarah, Ramesh Batra, Mario Strazzabosco, MingDe Lin, Bernhard Gebauer, Lynn Jeanette Savic, James Duncan, David C Madoff, Xuchen Zhang, Julius Chapiro

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Matuschewski, N. J., Sobirey, R., Revzin, M., Zeevi, T., Gross, M., Kasolowsky, V., Shewarega, A., Meister, E., Kao, T., Tefera, J., Bousabarah, K., Batra, R., Strazzabosco, M., Lin, M., Gebauer, B., Savic, L. J., Duncan, J., Madoff, D. C., Zhang, X., & Chapiro, J. (2025). Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma. Radiology. https://doi.org/10.1148/radiol.242750

Vancouver

Matuschewski NJ, Sobirey R, Revzin M, Zeevi T, Gross M, Kasolowsky V, et al. Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma. Radiology. 2025. doi:10.1148/radiol.242750

BibTeX
@article{Matuschewski2025,
  author = {Matuschewski, Nickolai J and Sobirey, Rabea and Revzin, Margarita and Zeevi, Tal and Gross, Moritz and Kasolowsky, Victor and Shewarega, Annabella and Meister, Ellen and Kao, Tabea and Tefera, Jonathan and Bousabarah, Khaled and Batra, Ramesh and Strazzabosco, Mario and Lin, MingDe and Gebauer, Bernhard and Savic, Lynn Jeanette and Duncan, James and Madoff, David C and Zhang, Xuchen and Chapiro, Julius},
  title = {Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma},
  journal = {Radiology},
  year = {2025},
  doi = {10.1148/radiol.242750}
}
Kostenlos starten →